Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis

NCT01722214 is registered in ClinicalTrials.gov with Innovaderm Research Inc. as lead sponsor.

NCT NCT01722214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01722214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicenter Placebo-controlled Trial on the Effect of Adalumumab on Vascular Inflammation in Patient With Moderate to Severe Psoriasis
Lead sponsor
Innovaderm Research Inc.
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2012
Completion date
January 31, 2016
Enrollment
107 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

coronary atherosclerosis, psoriasis, vascular inflammation